← Open Payments lookup

TIMOTHY MCAFEE: Open Payments

NPI 1548851785 · MILAN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$203 in 11 payments from 6 companies in 2025. Trend: 2023 $109 · 2024 $0 · 2025 $203

Food & beverage: $203
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$62
Otsuka America Pharmaceutical, Inc.3$54
ABBVIE INC.2$37
GlaxoSmithKline, LLC.1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15
PFIZER INC.1$14

Products named: CAPLYTA, REXULTI, TRELEGY ELLIPTA, QULIPTA, VRAYLAR, XIFAXAN, PREVNAR 20.

Industry payments across IN — which companies pay providers there.